These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 18836889)

  • 1. Mitochondrial fatty acid oxidation defects--remaining challenges.
    Gregersen N; Andresen BS; Pedersen CB; Olsen RK; Corydon TJ; Bross P
    J Inherit Metab Dis; 2008 Oct; 31(5):643-57. PubMed ID: 18836889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.
    Olsen RK; Olpin SE; Andresen BS; Miedzybrodzka ZH; Pourfarzam M; Merinero B; Frerman FE; Beresford MW; Dean JC; Cornelius N; Andersen O; Oldfors A; Holme E; Gregersen N; Turnbull DM; Morris AA
    Brain; 2007 Aug; 130(Pt 8):2045-54. PubMed ID: 17584774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level.
    Pedersen CB; Kølvraa S; Kølvraa A; Stenbroen V; Kjeldsen M; Ensenauer R; Tein I; Matern D; Rinaldo P; Vianey-Saban C; Ribes A; Lehnert W; Christensen E; Corydon TJ; Andresen BS; Vang S; Bolund L; Vockley J; Bross P; Gregersen N
    Hum Genet; 2008 Aug; 124(1):43-56. PubMed ID: 18523805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic investigation of cultivated fibroblasts from patients with mitochondrial short-chain acyl-CoA dehydrogenase deficiency.
    Edhager AV; Stenbroen V; Nielsen NS; Bross P; Olsen RKJ; Gregersen N; Palmfeldt J
    Mol Genet Metab; 2014 Mar; 111(3):360-368. PubMed ID: 24485985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative.
    Bentler K; Zhai S; Elsbecker SA; Arnold GL; Burton BK; Vockley J; Cameron CA; Hiner SJ; Edick MJ; Berry SA;
    Mol Genet Metab; 2016 Sep; 119(1-2):75-82. PubMed ID: 27477829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Tyni T; Paetau A; Strauss AW; Middleton B; Kivelä T
    Pediatr Res; 2004 Nov; 56(5):744-50. PubMed ID: 15347768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
    He M; Rutledge SL; Kelly DR; Palmer CA; Murdoch G; Majumder N; Nicholls RD; Pei Z; Watkins PA; Vockley J
    Am J Hum Genet; 2007 Jul; 81(1):87-103. PubMed ID: 17564966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heptanoic and medium branched-chain fatty acids as anaplerotic treatment for medium chain acyl-CoA dehydrogenase deficiency.
    Karunanidhi A; Basu S; Zhao XJ; D'Annibale O; Van't Land C; Vockley J; Mohsen AW
    Mol Genet Metab; 2023 Nov; 140(3):107689. PubMed ID: 37660571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?
    Olsen RK; Cornelius N; Gregersen N
    Mol Genet Metab; 2013; 110 Suppl():S31-9. PubMed ID: 24206932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disorders.
    van Eunen K; Volker-Touw CM; Gerding A; Bleeker A; Wolters JC; van Rijt WJ; Martines AM; Niezen-Koning KE; Heiner RM; Permentier H; Groen AK; Reijngoud DJ; Derks TG; Bakker BM
    BMC Biol; 2016 Dec; 14(1):107. PubMed ID: 27927213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium-chain acyl-CoA dehydrogenase deficiency associated with a novel splice mutation in the ACADM gene missed by newborn screening.
    Grünert SC; Wehrle A; Villavicencio-Lorini P; Lausch E; Vetter B; Schwab KO; Tucci S; Spiekerkoetter U
    BMC Med Genet; 2015 Jul; 16():56. PubMed ID: 26223887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory complex II defect in siblings associated with a symptomatic secondary block in fatty acid oxidation.
    Gargus JJ; Boyle K; Bocian M; Roe DS; Vianey-Saban C; Roe CR
    J Inherit Metab Dis; 2003; 26(7):659-70. PubMed ID: 14707514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of a novel mutation, G108D, in short-chain acyl-CoA dehydrogenase identified in subjects with short-chain acyl-CoA dehydrogenase deficiency.
    Shirao K; Okada S; Tajima G; Tsumura M; Hara K; Yasunaga S; Ohtsubo M; Hata I; Sakura N; Shigematsu Y; Takihara Y; Kobayashi M
    Hum Genet; 2010 Jun; 127(6):619-28. PubMed ID: 20376488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.
    Mosegaard S; Bruun GH; Flyvbjerg KF; Bliksrud YT; Gregersen N; Dembic M; Annexstad E; Tangeraas T; Olsen RKJ; Andresen BS
    Mol Genet Metab; 2017 Dec; 122(4):182-188. PubMed ID: 29122468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Missaglia S; Tavian D; Moro L; Angelini C
    Lipids Health Dis; 2018 Nov; 17(1):254. PubMed ID: 30424791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new case of short-chain acyl-CoA dehydrogenase deficiency: clinical, biochemical, genetic and (1)H-NMR spectroscopic studies.
    Battisti C; Forte F; Molinelli M; Funghini S; Pasquini E; Tassini M; Dotti MT; Federico A
    Neurol Sci; 2007 Dec; 28(6):328-30. PubMed ID: 18175080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluxomic evidence for impaired contribution of short-chain acyl-CoA dehydrogenase to mitochondrial palmitate β-oxidation in symptomatic patients with ACADS gene susceptibility variants.
    Dessein AF; Fontaine M; Joncquel-Chevalier Curt M; Briand G; Sechter C; Mention-Mulliez K; Dobbelaere D; Douillard C; Lacour A; Redonnet-Vernhet I; Lamireau D; Barth M; Minot-Myhié MC; Kuster A; de Lonlay P; Gregersen N; Acquaviva C; Vianey-Saban C; Vamecq J
    Clin Chim Acta; 2017 Aug; 471():101-106. PubMed ID: 28532786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple acyl-coenzyme A dehydrogenation disorder responsive to riboflavin: substrate oxidation, flavin metabolism, and flavoenzyme activities in fibroblasts.
    Rhead W; Roettger V; Marshall T; Amendt B
    Pediatr Res; 1993 Feb; 33(2):129-35. PubMed ID: 8433888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype?
    Lehotay DC; LePage J; Thompson JR; Rockman-Greenberg C
    J Inherit Metab Dis; 2004; 27(1):81-8. PubMed ID: 14970748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.